An endogenous dopaminergic neurotoxin, N-methyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells

Journal of Neurochemistry

Volumn 69, Issue 1, 1997, Pages 322-329

  Maruyama, Wakako ^a   Naoi, Makoto ^b   Kasamatsu, Toshio ^c   Hashizume, Yoshio ^d   Takahashi, Tsutomu ^e   Kohda, Kohfuku ^c   Dostert, Philippe ^f  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b NAGOYA INSTITUTE OF TECHNOLOGY   (Japan)

^c NAGOYA CITY UNIVERSITY   (Japan)

^d AICHI MEDICAL UNIVERSITY   (Japan)

^e Kohnan Women's College   (Japan)

^f PFIZER INC   (United States)

Author keywords

Apoptosis; Dopamine neuron; N methyl (R) salsolinol; Neurotoxin; Parkinson's disease

Indexed keywords

SALSOLINE DERIVATIVE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DOPAMINERGIC NERVE CELL; ETIOLOGY; HUMAN; HUMAN CELL; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0030957199     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69010322.x     Document Type: Article

References (36)

1. Anglade P., Vyas S., Javoy-Agid F., Herrero M. T., Michel P. P., Marquez J., Mouatt-Prigent A., Ruberg M., Hirsh E. C., and Agid Y. (1995) Apoptotic degeneration of nigral dopaminergic neurons in Parkinson's disease. Soc. Neurosci. Abstr. 21, 1250.
2. Bembenek M. E., Abell C. W., Chrisey L. A., Rowadowska M. D., Gessner W., and Brossi A. (1990) Inhibition of monoamine oxidase A and B by simple isoquinoline alkaloids: racemic and optically active 1,2,3,4-tetrahydro, 3,4-dihydro, and fully aromatic isoquinolines. J. Med. Chem. 33, 147-152.
3. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein dye binding. Anal. Biochem. 72, 248-254.
4. Cohen G., Pasik P., Cohen B., Leist A., Mytilineou C., and Yahr M. D. (1984) Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetraydropyridine in monkey. Eur. J. Pharmacol. 106, 209-210.
5. Deng Y., Maruyama W., Dostert P., Takahashi T., Kawai M., and Naoi M. (1995) Determination of the (R)-and (S)-enantiomers of salsolinol and N-methylsalsolinol by use of a chiral high-performance liquid chromatographic column. J. Chromatogr. B. 670, 47-54.
6. Dipasquale B., Marini A. M., and Youle R. J. (1991) Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons. Biochem. Biophys. Res. Commun. 181, 1442-1448.
7. Gavrieli Y., Sherman Y., and Ben-Sasson S. A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 491-501.
8. Hartley A., Stone J. M., Heron C., Cooper J. M., and Shapira A. H. V. (1994) Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease. J. Neurochem. 63, 1987-1990.
9. Johnson E. M. Jr. and Deckwerth T. L. (1993) Molecular mechanisms of developmental neuronal death. Annu. Rev. Neurosci. 16, 31-46.
10. Knoll J. (1988) The striatal dopamine dependency of life span in male rats. Longevity study with (-)deprenyl. Mech. Ageing Dev. 46, 237-262.
11. Kraml M. (1965) A rapid microfluorimetric determination of monoamine oxidase. Biochem. Pharmacol. 14, 1683-1685.
12. Langston J. W., Ballard P., Tetrud J. W., and Irwin I. (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980.
13. Markey S. P., Johannessen J. N., Chiueh C. C., Burns R. S., and Herkenham M. A. (1984) Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature 311, 464-466.
14. Maruyama W., Nakahara D., Ota M., Takahashi T., Takahashi A., Nagatsu T., and Naoi M. (1992) N-Methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study. J. Neurochem. 59, 395-400.
15. Maruyama W., Dostert P., Matsubara K., and Naoi M. (1995a) N-Methyl(R)-salsolinol produces hydroxyl radicals: involvement to neurotoxicity. Free Radic. Biol. Med. 19, 67-75.
16. Maruyama W., Dostert P., and Naoi M. (1995b) Dopamine-derived 1-methyl-6,7-dihydroxyisoquinolines as hydroxyl radical promoters and scavengers in the rat brain: in vivo and in vitro studies. J. Neurochem. 64, 2635-2643.
17. Maruyama W., Abe T., Tohgi H., Dostert P., and Naoi M. (1996a) A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in parkinsonian CSF. Ann. Neurol. 40, 119-122.
18. Maruyama W., Narabayashi H., Dostert P., and Naoi M. (1996b) Stereospecifc occurrence of a parkinsonism-inducing catechol isoquinoline, N-methyl(R)salsolinol, in the human intraventricular fluid. J. Neural Transm. 103, 1069-1076.
19. Maruyama W., Sobue G., Matsubara K., Hashizume Y., Dostert P., and Naoi M. (1997) A dopaminergic neurotoxin, 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigro-striatal system in the human brain. Neurosci. Lett. 223, 61-64.
20. +) in ventral mesencephalic-striatal co-culture in rat. Neurosci. Lett. 170, 191-194.
21. Mochizuki H., Goto G., Mori H., and Mizuno Y. (1996) Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci. 137, 120-123.
22. Mutoh T., Tokuda A., Marini A. M., and Fujiki N. (1994) 1-Methyl-4-phenylpyridinium kills differentiated PC12 cells with a concomitant change in protein phosphorylation. Brain Res. 661, 51-55.
23. Naoi M., Maruyama W., Zhang Y. H., Takahashi T., Deng Y., and Dostert P. (1995a) Enzymatic oxidation of the dopaminergic neurotoxin, 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, into 1,2-dimethyl-6,7-dihydroxyisoquinoline ion. Life Sci. 57, 1061-1066.
24. Naoi M., Maruyama W., and Dostert P. (1995b) Dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines: oxidation and neurotoxicity. Prog. Brain Res. 106, 227-239.
25. Naoi M., Maruyama W., Dostert P., Hashizume Y., Nakahara D., Takahashi T., and Ota M. (1996a) Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies. Brain Res. 709, 285-295.
26. Naoi M., Maruyama W., Dostert P., and Hashizume Y. (1996b) Animal model of Parkinson's disease induced by naturally-occurring 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline. Biogen. Amines 12, 135-147.
27. Naoi M., Maruyama W., Dostert P., Kohda K., and Kaiya T. (1996c) A novel enzyme enantio-selectively synthesizes (R)salsolinol, a precursor of a dopaminergic neurotoxin, N-methyl(R)salsolinol. Neurosci. Lett. 212, 183-186.
28. Östling O. and Johanson K. J. (1984) Microelectrophoretic study of radiation-induced DNA damage in individual mammalian cells. Biochem. Biophys. Res. Commun. 123, 291-298.
29. Sällström Baum S. and Rommelspacher H. (1994) Determination of total dopamine, R-and S-salsolinol in human plasma by cyclodextrin bonded-phase liquid chromatography with electrochemical detection. J. Chromatogr. B. 660, 235-241.
30. Singh N. P., McCoy M. T., Tice R. R., and Schneider E. L. (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175, 184-191.
31. Takanashi T., Deng Y., Maruyama W., Dostert P., Kawai M., and Naoi M. (1994) Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system. J. Neural Transm. Gen. Sect. 98, 107-118.
32. Teitel S., O'Brien J., and Brossi A. (1972) Alkaloids in mammalian tissues. 2. Synthesis of (+) and (-)-1-substituted-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines. J. Med. Chem. 15, 845-846.
33. Walkinshaw G. and Waters C. W. (1995) Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implication for the treatment of Parkinson's disease. J. Clin. Invest. 95, 2458-2464.
34. Wolvetang E. J., Johnson K. L., Knauer K., Ralph S. J., and Linnane A. W. (1994) Mitochondrial respiratory chain inhibitors induce apoptosis. FEBS Lett. 339, 40-44.
35. + in vivo. Eur. J. Pharmacol. 243, 241-247.
36. Youdim M. B. H., Ben-Shachar D., and Riederer P. (1990) The role of monoamine oxidase, iron-melanin interaction, and intracellular calcium in Parkinson's disease. J. Neural Transm. Suppl. 32, 239-248.